Bosh sahifa128940 ā¢ KRX
add
Hanmi Pharm Co Ltd
Yopilish kursi
282Ā 000,00Ā ā©
Kunlik diapazon
281Ā 000,00Ā ā© - 284Ā 500,00Ā ā©
Yillik diapazon
214Ā 500,00Ā ā© - 375Ā 000,00Ā ā©
Bozor kapitalizatsiyasi
3,63Ā trln KRW
OŹ»rtacha hajm
52,56Ā ming
Narx/foyda
33,43
Dividend daromadliligi
0,44%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 390,95Ā mlrd | -3,16% |
Joriy xarajat | 154,57Ā mlrd | 3,16% |
Sof foyda | 42,61Ā mlrd | -22,54% |
Sof foyda marjasi | 10,90 | -19,97% |
Har bir ulushga tushum | ā | ā |
EBITDA | 83,51Ā mlrd | -17,20% |
Amaldagi soliq stavkasi | 16,03% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 218,53Ā mlrd | -37,46% |
Jami aktivlari | 1,98Ā trln | 0,69% |
Jami passivlari | 714,64Ā mlrd | -11,26% |
Umumiy kapital | 1,27Ā trln | ā |
Tarqatilgan aksiyalar | 12,68Ā mln | ā |
Narxi/balansdagi bahosi | 3,21 | ā |
Aktivlardan daromad | 7,37% | ā |
Kapitaldan daromad | 8,48% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 42,61Ā mlrd | -22,54% |
Operatsiyalardan naqd pul | 79,35Ā mlrd | -37,88% |
Sarmoyadan naqd pul | -144,97Ā mlrd | -201,02% |
Moliyadan naqd pul | -41,10Ā mlrd | -337,00% |
Naqd pulning sof oŹ»zgarishi | -107,92Ā mlrd | -251,06% |
BoŹ»sh pul | 54,67Ā mlrd | -45,67% |
Haqida
Hanmi Pharm Co., Ltd. is a South Korean pharmaceutical company that is headquartered in Seoul. Wikipedia
Tashkil etilgan
1973
Sayt
Xodimlar soni
2Ā 330
